A recent outbreak of various respiratory diseases has been spreading throughout West Texas. This includes COVID-19, influenza ...
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
4d
WWMT Grand Rapids/Lansing on MSN'Quad-demic' hitting the U.S. with four respiratory illnesses on the riseIt’s what’s being called a “Quad-demic,” with cases on the rise for COVID-19, Respiratory syncytial virus (RSV), Influenza, ...
A virus rapidly spreading in China is also circulating in the United States, causing concern among health experts.
6d
GlobalData on MSNShionogi’s RSV antiviral reduces viral load in Phase II human challenge trialShionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.
The North Carolina Department of Health and Human Services on Wednesday updated its weekly Respiratory Virus Summary Dashboard, which shows an increase in flu activity and flu-related deaths, bringing ...
To accommodate an influx of patients suffering from respiratory illnesses, Union Health has installed a portable medical tent ...
RALEIGH — The N.C. Department of Health and Human Services on Wednesday reported an increase in flu activity and flu-related deaths, bringing the total number of deaths this season to 117.
(Alliance News) - hVIVO PLC on Monday said it has signed a contract with Inhalon Biopharma Inc to test its antiviral candidate to treat respiratory syncytial virus. The London-based contract research ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results